Literature DB >> 17512193

Neurosteroids alter glutamate-induced changes in neurite morphology of NG108-15 cells.

Tobias Johansson1, Martin Elfverson, Carolina Birgner, Per-Anders Frändberg, Fred Nyberg, Pierre Le Grevès.   

Abstract

Activation of the NMDA receptor leads to increased intracellular Ca2+ levels ([Ca2+]i) which induces outgrowth of and morphologic changes in the neurites of the NG108-15 cell line. This effect can be blocked by antagonists for this glutamate receptor subtype (e.g. ifenprodil or AP5). We have previously shown that nanomolar concentrations of various neurosteroids modulate ifenprodil binding to the NMDA receptor. To investigate whether this interaction affects the functioning of the receptor, we studied the effect of 24 and 48 h of pregnenolone sulphate (PS) or pregnanolone sulphate (3alpha5betaS) on glutamate-stimulated NG108-15 cells. Unexpectedly, the neurosteroids themselves had an inhibitory effect on glutamate-induced changes in neurite patterns. This effect was comparable to that of ifenprodil or AP5. Moreover, the effect of combined treatment with 3alpha5betaS and ifenprodil on neurite morphology indicated a functional interaction between the substances. Interestingly, PS induced cell detachment over time, an effect that was further enhanced by ifenprodil. Cell detachment was also seen after 48 h of treatment with 3alpha5betaS; however, the effect was blocked by ifenprodil and weaker than that of PS. The interaction with the NR2B-selective antagonist ifenprodil indicates that this NMDA receptor subunit may be involved in neurosteroid-induced NG108-15 cell detachment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17512193     DOI: 10.1016/j.jsbmb.2007.03.024

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  1 in total

1.  Altered apoptotic responses in neurons lacking RhoB GTPase.

Authors:  Sara Barberan; Kara McNair; Khalil Iqbal; Nicola C Smith; George C Prendergast; Trevor W Stone; Stuart R Cobb; Brian J Morris
Journal:  Eur J Neurosci       Date:  2011-11-18       Impact factor: 3.386

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.